Drug Diversion: Investigating and Making a Case Donna H. Mooney, RN, MBA June 6, 2012 NCSBN – Attorney/Investigator Summit Ft. Lauderdale, Florida.

Slides:



Advertisements
Similar presentations
Nonmedical Use of Prescription Medications Specific penalties will vary from state to state…see your states statutes for details.
Advertisements

Reporting Child Abuse and Neglect
Inpatient Medication Inventory Management: Ward Stock
AcuDose Medicine Cabinet
PHARMACY AUTOMATION GUIDANCE FOR THE CONTROLLED SUBSTANCE COORDINATOR
National Take Back Initiative III. On October 29 from 10 a.m. to 2 p.m. Local Law Enforcement & the Drug Enforcement Administration (DEA) will give.
Bridging Medication Across Settings of Care Richard Ricker, RPH, MBA Sparrow Hospital Barbara J. Smith, LBSW, MS, CHC, NHA Burcham Hills DATE: May 29,
1 2 Note: The following slides represent suggestions to enhance the writing of a SAR narrative. This information should be used in conjunction with the.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015.
Confidential 1 Electronic Prescribing of Controlled Substances (EPCS) Part 1 of a 3 Part Series Chuck Klein, Ph.D. GM/Director, Medication Management.
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
Forensics/Harrison.  DEA Drug Schedule Site DEA Drug Schedule Site.
Medication History: Keeping our patients safe. How do we get all of the correct details?
Controlling Controlled Substances Russell Griffin McKinney Fire / EMS EMS Coordinator.
Mayor Jacobs Prescription Drug Task Force Update Presentation to Board of County Commissioners September 23, 2014.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
Prescription Drug Abuse/Misuse in Florida 2010 Florida Prevention Conference Orlando, Florida September 30, 2010 Hal Johnson, MPH Substance Abuse Program.
Reporting Requirements for School Staff Presented by Nancy Hungerford November 30, 2011 Presented by Nancy Hungerford November 30, 2011.
Lesson: Using Medicines Wisely Welcome 9 th graders from Gainesville High School! By: Kemi Dada, Kathy Lertsuwankul, Ashley Sansaricq, Scotty Pepper,
© 2010 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 4 Comprehensive Drug Abuse and Prevention Control Act: A Closer Look Jahangir Moini, MD,
California State Board of Pharmacy Continuing Education Program Senate Bill 151 (Burton)
Drug Abusing Nurse Profile High Stress Present when patient in pain Present when patient dies Demand for perfection.
Medical Law and Ethics Lesson 3: Documentation and Regulations.
Chapter 1. OBJECTIVES  see p-2 of text book KEY TERMS / CONCEPTS  controlled substances  Drug Enforcement Administration (DEA)  drug standards  Food.
The Impaired Healthcare Worker Lake Regional Health System.
For Pain or Not for Pain: Methadone Madness
Introduction to Pharmacology. Nurse Practice Act Defines scope Role of the LPN.
Introduction to Pharmacology. Nurse Practice Act Defines scope Role of the LPN.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
 Enacted into law as part of the Comprehensive Drug Abuse Prevention and Control Act of  Regulation of the manufacture, importation, possession,
Hospital Pharmacy. 2 Introduction Hospital pharmacy: most challenging area to work Some pharmacies open 24 hours a day, 7 days a week Technicians: flexibility.
Vital Statistics If you are doing the recording, leave no entries blank, verify the spelling of names, avoid abbreviations. Do not correct or erase, provide.
LECTURE FOR ASSIGNMENT 1 AND 2
CONTROLLED SUBSTANCES AND ALCOHOL USE TESTING REGULATIONS FOR DRIVERS.
Department of Patient RelationsMeasuring to Achieve Patient Safety Safety Observer’s Orientation.
Drug Diversion for Investigators. Training Objectives 1.Correctly list the methods used to divert drugs. 2.Define the term “doctor shopper” as it relates.
MmPHR Use Cases Oxyconton Fraud Business Model Rubina Lakhani March 2, 2016.
Preventing Medication Diversion Developed by the: University of Wisconsin Oshkosh and Wisconsin Department of Health Services.
Drug Enforcement Administration Greater Kansas City Chapter American Society for Pain Management Nursing October 24, 2015 Judy R. Williams Group Supervisor.
Georgia’s New and Improved PDMP. Greg Reybold, J.D. VP Public Policy & Association Counsel Georgia Pharmacy Association.
Controlled Substances
North Carolina vs. United States Drug Schedules.  In NC, drugs are classified by “schedule” according to: ▪ Dangeousness ▪ Risk of Addiction  The charge.
Drug Scheduling ● This chapter will focus on the deadliest to the least addictive drugs ● There will be a test, so study.
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Pennsylvania's Prescription Drug Monitoring Program (PDMP) May 17, 2016.
Medication Administration
Daniel Sifuentes Gabriel Vazquez 5th period
Quick Regulatory Guide
Opioids, Synthetics and Cannabis……. OH MY!
SAY KNOW TO DRUGS Arjeta Prenaj.
North Carolina Medical Board
“Your life can change forever in a matter of seconds”.
Controlled substance compliance
Federal Regulations requirements for opioid prescription course
ALLEGATIONS OF ABUSE Internal Occurrence Reporting and Investigation.
PRESCRIPTION MONITORING PROGRAMS
Legal Aspects Affecting the Administration of Medications
Conducting a Drug Diversion Investigation
Prescription Drug Monitoring Program
Prescription Drug Monitoring Program
Controlled Substances
Anabolic Steroids, Laws
Lesson: Using Medicines Wisely
Controlled Substances
Prescription Drug Monitoring Program
Regulation The legislation that is meant to regulate and control
DEA Schedule of drugs Top 5 Drug Busts.
Collection of Drug Evidence
Controlled Substances
ARKANSAS EXPANDED EKITS
OSU Controlled Substances Training Module for Researchers
Presentation transcript:

Drug Diversion: Investigating and Making a Case Donna H. Mooney, RN, MBA June 6, 2012 NCSBN – Attorney/Investigator Summit Ft. Lauderdale, Florida

What is a Controlled substance? A substance that has been classified as having a potential for abuse/ addiction Controlled substances are classified in schedules ranging from Schedule I – Schedule VI

Drug Classifications 1. Schedule I – street drugs – they have no medicinal purpose (cocaine – PCP – methamphetamine – heroin) 2. Schedule II – high potential for abuse - Narcotics (Hydromorphone – Demerol – Morphine – Fentanyl) The new kid on the block - Nucynta

Drug Classifications 3. Schedule III – Opiates – Lesser potential for abuse that the IIs but also highly addictive (Oxycodone – Hydrodocone – T#3s) 4. Schedule IV – Benzos, Tranqs and sleeping pills (Xanax – Valium – Dalmane – Lorazapam)

Drug Classifications 5. Schedule V – can obtain without a prescription but you must sign the narcotic ledger at the pharmacy – cough syrups with codeine; paragoeric containing compounds 6. Schedule VI – Marijhuana – NC is the only state that has a specific schedule for Marijhuana

Jurisdictional Issues a. Federal Agencies 1. DEA b. State Agencies 1. SBI c. Local law enforcement 1. Local sheriffs and police departments d. Regulatory Agencies 1. Board of Pharmacy 2. Board of Medicine

Understanding Accountability Systems a.Manufacturer/ Distribution networks (lot numbers) b.Pharmacy CV logs – CII files – Computerized records – CSRS records – Triplicate prescriptions

Understanding Accountability Systems c. Hospitals 1. Automated dispensing systems – SureMed Pyxis - Accudose hour count sheets 3. ORs/Anesthesia/PACUs/ERs

Understanding Accountability Systems d. Long Term Care Facilities 1. ordering meds/ log in 2. narcotic cabinet/box 3. shift count 4. Emergency box e. Methadone facilities f. MD offices - (samples) g. Residential Hospices/Home Care situations

Detecting Diversion What is diversion? – GS (a) (14) Paraphrased – you sign out a controlled substance and there is no further documentation in the records to substantiate administration of the drug to the ultimate user (patient). NCAC (b) (2) – illegally obtaining, possessing or distributing drugs or alcohol for personal or other use, or other violations of GS to *GS (a) (10) (11) (13) (14)*

Identifying a Narcotic Discrepancy A narcotic discrepancy will ALWAYS be a number and represents something not accounted for, or missing. There is a difference between a narcotic discrepancy and poor practice. Examples of poor practice will be things like illegible handwriting; time discrepancies, documentation of a controlled substance to a patient only when the suspect works, etc.

Tools for Determining Diversion a. The agency policy for documentation of controlled substances b. The physicians orders c. The Controlled Substance sign out record/Pyxis log d. The MAR/EMAR – need to understand how the system works- Does the med have to be scanned with the patient ID? Does the removal automatically document the med? e. Access (unique identifier – log in code, hospital badge, etc.) f. Waste records

Other investigative tools a. Prior counseling records b. Body fluid specimens c. Background information Prior employment – NURSYS check – prior Board records – CSRS – CBC

Performing an accountability audit a.Anesthesia b.Long term care c.General Duty d.Emergency departments

Methods of Diversion a.Substitution/ Dilution b.Manipulation of narcotic records c.Prescription forgery/Illegally obtaining – calling in Rxs d.Failure to document e.Inaccurate waste records

Preparing for the report Writing the report may be the most critical part of the case. Remember If you cant explain it simply – you dont understand it well enough. Albert Einstein

Writing the Report Always answer the 5 Ws Who – What –When – Where – Why (should be answered in the first few paragraphs) Be sure that you validate any statements submitted from the facility. Be sure that you validate any audits sent by the facility

Writing the Report 4. Be sure you verify the dates in the reported material. 5. If you reference a specific discrepancy, be sure those dates are included in your audit. 6. Give the total number of transactions and the discrepancy rate (there is a big difference between 600 transactions and 30 discrepancies for a 5% discrepancy rate vs. 600 transactions and 480 discrepancies for an 80% discrepancy rate).

Writing the report – cont. 7. Be specific about the dates of the audit (ex. – there is a big difference between an audit spanning Feb and March 2011 – approx. 8 weeks vs. February 22- March 7, 2011 – approx. 2 weeks). 8. Summarize your audit (after the summary of the actual discrepancies you can then add the things you learned that suggest poor practice 9. Be sure and have the entire suspect interview in the file.

Writing the Report Always include specifically what the suspect admitted/denied. Always ask them if they took the medication – do not assume that because they are not admitting diversion that they will say – no.

Example of report On April 15, 2011 Joan Smith was assigned to work the 7p-7a shift on the 300 Hall at Scotties Hotties LTC Facility. The nurse that relieved Ms. Smith on the 7a- 7p shift received complaints from several alert and oriented clients that reported not getting pain medication the previous shift when they requested it. The day shift nurse checked the MAR and each of the patients that complained had controlled substances signed out to them by Ms. Smith as often as the order allowed on Ms. Smiths shift. The day shift nurse reported this to the supervisor and this resulted in an investigation being conducted.

Example of report - cont A limited accountability audit was conducted on Ms. Smiths sign-outs of controlled substances from February 15 – April 15, The substances audited included: Oxycodone, Morphine and Xanax. There were 150 transactions and 125 discrepancies for an 80% discrepancy rate. The results of the audit included but may not be limited to: a.Controlled substances were signed out without further documentation on the front or back of the MAR to substantiate administration of the drug to the client b.Controlled substances were signed out to patients without a physicians order c.Controlled substances were signed out without accountability for waste

Example of report – cont. Additionally, during the audited period, Ms. Smith was the only nurse to document giving Oxycodone to Client TS. On two (2) occasions Ms. Smith documented Client WR was sleeping comfortably with no complaints of pain, but she signed out two (2) Oxycodone to the client. Although there were only a few discrepancies in February, there was a big increase in the discrepancy rate after March 22, 2011 when Ms. Smith returned to the agency after injuring her back. When questioned by Board staff Ms. Smith denied diverting the medication for herself or anyone else. Ms. Smith admitted that she was sloppy with her documentation and that she often forgot to document her medications when it was busy.

Closing 1.Having accurate information in the audit is critical in proving these cases. 2.Having an accurate and complete accounting of the suspect nurse interview is critical to the prosecution of the case and for attempts at settling a case 3.Proving diversion is easy – proving the suspect nurse consumed the medication is a little more difficult BUT remember

Closing – cont. The difficult we do immediately - the impossible takes a little longer! QUESTIONS?

Have a great day!!!! Donna H. Mooney, RN, MBA Manager, Discipline Proceedings North Carolina Board of Nursing ext 285